Formation Bio
Formation Bio is an AI-native pharmaceutical company building the pharma company of the future. Rather than applying AI to drug discovery, it focuses on drug development — acquiring and in-licensing clinical-stage drug candidates from pharma companies, universities, and biotech firms, then running them through clinical development far more efficiently than industry standards using its proprietary AI-native platform, data, and fine-tuned models. Led by CEO Benjamine Liu and CTO Linhao Zhang, the company raised a $372M Series D in 2024 led by a16z with participation from Sanofi, Sequoia, Thrive, Emerson Collective, and others, and partners with Sanofi and OpenAI on custom models for the drug development lifecycle. Formation Bio does not currently publish a public developer API; this profile tracks its identity and public web surface.
Formation Bio is profiled on the APIs.io network. Tagged areas include Company, Pharmaceutical, Drug Development, Artificial Intelligence, and Biotechnology.
Formation Bio’s developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API